INOVIO PHARMACEUTICALS INC
INONASDAQ🏆 #4001 by market capEarnings Nov 9US Equity
$0.77▼ $0.16 (−16.89%)
🌙 After hours$0.76▼ 1.04%Regular close · extended-hours price shownTrack INO
Get earnings, price moves & breaking news on Telegram
24h▼ 16.9%
7d▼ 8.0%
14d▼ 26.1%
30d▼ 31.1%
ytd▼ 55.8%
1y▼ 68.2%
🏦Market Cap
$80M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
58.9%
Healthy
💵FCF Margin
5172.3%
Strong
⚖️P/S Ratio
318.4x
Expensive
Otter Score
—
Insufficient data
INOVIO PHARMACEUTICALS INC
INOAnalyst Ratings
Price
$0.7718
Total
17
Raised
1
Lowered
5
Avg PT
$2.75
H / L
$3 / $3
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Jefferies | Upgraded | Hold → Buy | 2026-08-13 | $3.00 | +288.70% |
Piper Sandler | Reiterated | Overweight | 2026-08-03 | $6.00 | +677.40% |
HC Wainwright & Co. | Reiterated | Neutral | 2026-06-01 | — | — |
RBC Capital | Reiterated | Sector Perform | 2025-05-14 | $8.00 | +936.50% |
Oppenheimer | Reiterated | Outperform | 2025-05-14 | $40.00 | +5082.70% |
JMP Securities | Reiterated | Market Outperform | 2025-01-10 | — | — |
Maxim Group | Downgraded | Buy → Hold | 2022-11-08 | — | — |
B of A Securities | Downgraded | Neutral → Underperform | 2022-10-31 | — | — |
Roth Capital | Downgraded | Neutral → Sell | 2020-11-16 | — | — |
Cantor Fitzgerald | Downgraded | Overweight → Neutral | 2020-09-27 | — | — |
Stifel | Downgraded | Buy → Hold | 2020-06-25 | — | — |
Benchmark | Reiterated | Buy | 2020-05-21 | — | — |
PiperJaffray | Reiterated | Overweight | 2020-01-03 | — | — |
Aegis Capital | Reiterated | Buy | 2016-11-07 | — | — |
Brean Capital | Reiterated | Buy | 2016-03-13 | — | — |
H.C. Wainwright | Reiterated | Buy | 2015-03-12 | $2.50 | +223.90% |
Stifel Nicolaus | Reiterated | Buy | 2014-05-07 | — | — |
Institution
Jefferies
Upgraded · Hold → Buy · 2026-08-13
$3.00
+288.70%
Piper Sandler
Reiterated · Overweight · 2026-08-03
$6.00
+677.40%
HC Wainwright & Co.
Reiterated · Neutral · 2026-06-01
—
—
RBC Capital
Reiterated · Sector Perform · 2025-05-14
$8.00
+936.50%
Oppenheimer
Reiterated · Outperform · 2025-05-14
$40.00
+5082.70%
JMP Securities
Reiterated · Market Outperform · 2025-01-10
—
—
Maxim Group
Downgraded · Buy → Hold · 2022-11-08
—
—
B of A Securities
Downgraded · Neutral → Underperform · 2022-10-31
—
—
Roth Capital
Downgraded · Neutral → Sell · 2020-11-16
—
—
Cantor Fitzgerald
Downgraded · Overweight → Neutral · 2020-09-27
—
—
Stifel
Downgraded · Buy → Hold · 2020-06-25
—
—
Benchmark
Reiterated · Buy · 2020-05-21
—
—
PiperJaffray
Reiterated · Overweight · 2020-01-03
—
—
Aegis Capital
Reiterated · Buy · 2016-11-07
—
—
Brean Capital
Reiterated · Buy · 2016-03-13
—
—
H.C. Wainwright
Reiterated · Buy · 2015-03-12
$2.50
+223.90%
Stifel Nicolaus
Reiterated · Buy · 2014-05-07
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space